{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:31:44Z","timestamp":1792157504043,"version":"4.4.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,3,20]],"date-time":"2006-03-20T00:00:00Z","timestamp":1142812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1007\/s00415-006-0093-3","type":"journal-article","created":{"date-parts":[[2006,3,15]],"date-time":"2006-03-15T21:18:42Z","timestamp":1142457522000},"page":"411-416","source":"Crossref","is-referenced-by-count":57,"title":["Human African trypanosomiasis\u2013neurological aspects"],"prefix":"10.1007","volume":"253","author":[{"given":"P. G. E.","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,3,20]]},"reference":[{"key":"93_CR1","unstructured":"Vickerman K (1997) Landmarks in trypanosome research. In: Hide G, Mottram JC, Coombs GH, Holmes PH (eds) Trypanosomiasis and leishmaniasis. Cab International, Oxford, pp 1\u201337"},{"key":"93_CR2","unstructured":"Williams BI (1996) African trypanosomiasis. In: Cox FEAG (ed) The Wellcome Trust illustrated history of tropical diseases. The Wellcome Trust, London, pp 178\u2013191"},{"key":"93_CR3","unstructured":"Atouguia JLM, Kennedy PGE (2000) Neurological aspects of human African trypanosomiasis. In: Davis LE, Kennedy PGE (eds) Infectious diseases of the nervous system. Butterworth-Heinemann, Oxford. pp 321\u2013372"},{"key":"93_CR4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1172\/JCI200421052","volume":"113","author":"Kennedy","year":"2004","unstructured":"Kennedy PGE (2004) Human African trypanosomiasis of the CNS: current issues and challenges. J Clin Invest 113:496\u2013504","journal-title":"J Clin Invest"},{"key":"93_CR5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0001-706X(93)90089-T","volume":"54","author":"Kuzoe","year":"1993","unstructured":"Kuzoe FA (1993) Current situation of African trypanosomiasis. Acta Tropica 54:153\u2013162","journal-title":"Acta Tropica"},{"key":"93_CR6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0001-706X(02)00237-1","volume":"85","author":"Donelson","year":"2002","unstructured":"Donelson JE (2002) Antigenic variation and the African trypanosome genome. Acta Tropica 85:391\u2013404","journal-title":"Acta Tropica"},{"key":"93_CR7","unstructured":"Barry JD (1997) The biology of antigenic variation in African trypanosomes. In: Hide G, Mottram JC, Coombs GH, Holmes PH (eds) Trypanosomiasis and leishmaniasis. Cab International, Oxford, pp 89\u2013107"},{"key":"93_CR8","unstructured":"Apted FIC (1970) Clinical manifestations and diagnosis of sleeping sickness. In: Mulligan HW (ed) The African trypanosomiasis. George Allen and Unwin, London, pp 661\u2013683"},{"key":"93_CR9","first-page":"124","volume":"69","author":"Duggan","year":"1966","unstructured":"Duggan AJ, Hutchington MP (1966) Sleeping sickness in Europeans: a review of 109 cases. J Trop Med Hyg 69:124\u2013131","journal-title":"J Trop Med Hyg"},{"key":"93_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-308X(08)60410-8","volume":"33","author":"Pepin","year":"1994","unstructured":"Pepin J, Milord F (1994) The treatment of human African trypanosomiasis. Adv Parasitol 33:1\u201347","journal-title":"Adv Parasitol"},{"key":"93_CR11","unstructured":"(1998) Control and surveillance of African trypanosomiasis. Report of a WHO expert committee. World Health Organization. Geneva, Switzerland, Technical Report Series No. 881, 114 pp"},{"key":"93_CR12","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1086\/374645","volume":"187","author":"Lejon","year":"2003","unstructured":"Lejon V, Reiber H, Legros D, Dj\u00e9 N, Magnus E, Wouters I, Sindic CJM, B\u00fcscher P (2003) Intrathecal immune response pattern for improved diagnosis of central nervous systems involvement in trypanosomiasis. J Infect Dis 187:1475\u20131483","journal-title":"J Infect Dis"},{"key":"93_CR13","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1046\/j.1365-3156.2002.00917.x","volume":"7","author":"Lejon","year":"2002","unstructured":"Lejon V, Legros D, Richer M, Ruiz JA, Jamonneau V, Truc P, Doua F, Dj\u00e9 N, N\u2019Siesi FX, Bisser S, Magnus E, Wouters I, Konings J, Vervoort T, Sultan F, B\u00fcscher P (2002) IgM quantification in the cereprospinal fluid of sleeping sickness patients by a latex card agglutination test. Trop Med Int Health 7:685\u2013692","journal-title":"Trop Med Int Health"},{"key":"93_CR14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.18.1.133-146.2005","volume":"18","author":"Chappuis","year":"2005","unstructured":"Chappuis F, Loutan L, Simarro P, Lejon V, B\u00fcscher P (2005) Options for field diagnosis of Human African Typanosomiasis. Clin Microbiol Rev 18:133\u2013146","journal-title":"Clin Microbiol Rev"},{"key":"93_CR15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0001-706X(02)00029-3","volume":"82","author":"Solano","year":"2002","unstructured":"Solano P, Jamonneau V, N\u2019Guessan P, N\u2019Dri L, Dj\u00e9 NN, Miezan TW, Lejon V, B\u00fcscher P, Garcia A (2002) Comparison of different DNA preparation protocols for PCR diagnosis of human African trypanosomiasis in Cote d\u2019Ivoire. Acta Tropica 82:349\u2013356","journal-title":"Acta Tropica"},{"key":"93_CR16","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0035-9203(90)90124-W","volume":"84","author":"Fairlamb","year":"1990","unstructured":"Fairlamb AH (1990) Future prospects for the chemotherapy of human trypanosomiasis. 1. Novel approaches to the chemotherapy of trypanosomiasis. Trans R Soc Trop Med Hyg 84:613\u2013617","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"93_CR17","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0140-6736(89)92340-4","volume":"1","author":"Pepin","year":"1989","unstructured":"Pepin J, Guern C, Ethier L, Milord F, Mpia B, Mansinsa D (1989) Trial of prednisolone for prevention of melarsoprol induced encephalopathy in gambiense sleeping sickness. Lancet 1:1246\u20131249","journal-title":"Lancet"},{"key":"93_CR18","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1086\/429929","volume":"191","author":"Schmid","year":"2005","unstructured":"Schmid C, Richer M, Bilenge CMM, Josenando T, Chappuis F, Manthelot CR, Nangouma A, Doua F, Asumu PN, Simarro PP, Burri C for the IMPAMEL 11 Study (2005) Effectiveness of a 10- day melarsoprol schedule for the treatment of late-stage human African Trypanosomiasis: confirmation from a multinational study (IMPAMEL 11). J Infect Dis 191:1922\u20131931","journal-title":"J Infect Dis"},{"key":"93_CR19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0035-9203(99)90151-7","volume":"93","author":"Legros","year":"1994","unstructured":"Legros D, Evans S, Maiso F, Enyaru JCK, Mbulamberi D (1994) Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda. Trans R Soc Trop Med Hyg 93:439\u2013442","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"93_CR20","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1007\/s00436-002-0766-5","volume":"90","author":"Burri","year":"2003","unstructured":"Burri C, Brun R (2003) Eflornithine for the treatment of human African trypanosomiasis. Parasitol Res 90 (Suppl 1):S49\u2013S52","journal-title":"Parasitol Res"},{"key":"93_CR21","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(02)08569-0","volume":"359","author":"Kennedy","year":"2002","unstructured":"Kennedy PGE, Murray M, Jennings F, Rodgers J (2002) Sleeping sickness: new drugs from old? Lancet 359:1695\u20131696","journal-title":"Lancet"},{"key":"93_CR22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0165-5728(99)00196-4","volume":"100","author":"Kennedy","year":"1999","unstructured":"Kennedy PGE (1999) The pathogenesis and modulation of the post-treatment reactive encephalopathy in a mouse model of human African trypanosomiasis. J Neuroimmunol 100:36\u201341","journal-title":"J Neuroimmunol"},{"key":"93_CR23","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1086\/323479","volume":"184","author":"MacLean","year":"2001","unstructured":"MacLean L, Odiit M, Sternberg JM (2001) Nitric oxide and cytokine synthesis in human African trypanosomiasis. J Infect Dis 184:1086\u20131090","journal-title":"J Infect Dis"},{"key":"93_CR24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0035-9203(02)90115-X","volume":"96","author":"Lejon","year":"2002","unstructured":"Lejon V, Lardon J, Kenis G, Pinoges L, Legros D, Bisser S, N\u2019Siesi X, Bosmans E, B\u00fcscher P (2002) Interleukin (IL)-6, IL-8 and IL-10 in serum and CSF of Trypanaosoma brucei gambiense sleeping sickness patients before and after treatment. Trans R Soc Trop Med Hyg 96:329\u2013333","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"93_CR25","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1073\/pnas.94.8.4167","volume":"94","author":"Kennedy","year":"1997","unstructured":"Kennedy PGE, Rodgers J, Jennings F, Murray M, Leeman S, Burke JM (1997) A substance P antagonist, RP-67.580 amelioarates a mouse meningoencephalitic response to Trypanosoma brucei brucei. Proc Natl Acad Sci USA 94:4167\u20134170","journal-title":"Proc Natl Acad Sci USA"},{"key":"93_CR26","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1093\/brain\/awg160","volume":"126","author":"Kennedy","year":"2003","unstructured":"Kennedy PGE, Rodgers J, Bradley B, Hunt SP, Gettinby G, Leeman S, de Felipe C, Murray M (2003) Clinical and neuroinflammatory responses to meningoencephalitis in Substance P receptor knockout mice. Brain 126:1683\u20131690","journal-title":"Brain"},{"key":"93_CR27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2990.1997.tb01206.x","volume":"23","author":"Jennings","year":"1997","unstructured":"Jennings FW, Gichuki CW, Kennedy PGE, Rodgers J, Hunter CA, Murray M, Burke JM (1997) The role of the polyamine inhibitor eflornithine in the neuropathogenesis of experimental murine African trypanosomiasis. Neuropathol Appl Neurobiol 23:225\u2013234","journal-title":"Neuropathol Appl Neurobiol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-006-0093-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-006-0093-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-006-0093-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T06:31:49Z","timestamp":1586759509000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-006-0093-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,20]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["93"],"URL":"https:\/\/doi.org\/10.1007\/s00415-006-0093-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,20]]}}}